[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fc9iHNx_OoejBSZYKRXyemKfvKS6597IAWMRjbW90rXI":8,"$fBJFRiWUw58kn-jSJWYZsiBQaWBhHRA5DegfpSgWWsxQ":55,"$fpJqQsjvgGDDBhbBojw-p2wAmEV6EBVmjtDF1LUDAyN4":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},56183,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"食管癌治疗新方向：免疫治疗与化疗的科学解析","","https://ystcdn.venuertc.com/venue/AI/470e984c-193c-402f-92ee-586a51387492.jpg","\u003Cdiv class=\"esoph-drug-guide-container\" style=\"max-width:780px;margin:0 auto;padding:32px 20px 32px 20px;background:#fcfbfa;box-shadow:0 4px 28px #e7e3e3;border-radius:20px;\">\n  \u003Ch1 id=\"material_title\" class=\"esoph-drug-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">食管癌治疗新方向：免疫治疗与化疗的科学解析\u003C/h1>\n  \u003Cdiv class=\"esoph-drug-block esoph-bg-title\" style=\"background:linear-gradient(120deg,#f3f5fa 60%,#e9f7f4);margin-bottom:28px;padding:18px 24px 14px 24px;border-radius:14px;\">\n    \u003Cp style=\"font-size:1.12em;color:#24485c;line-height:1.8;\">\u003Cstrong>说到食管癌的药物治疗，新的免疫药物和化疗药物组合引起了很多关注。其中，信迪利单抗等免疫抑制剂，联合顺铂、白蛋白紫杉醇等化疗药，是当前主流的推荐。到底这些药怎么用？需要注意什么？今天为大家详细拆解免疫治疗与化疗用药的7个关键细节，让大家用药更有底气，远离风险。\u003C/strong>\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 剂型与成分一览 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.27em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(238, 250, 247) 67%, rgb(252, 246, 237) 100%); padding: 12px 20px 5px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    01 药品成分和剂型特点\n  \u003C/h2>\n  \u003Cdiv class=\"esoph-section\">\n    \u003Cul class=\"esoph-info-list\">\n      \u003Cli>\n        \u003Cspan class=\"esoph-pill-icon\">💡\u003C/span>\n        信迪利单抗：为注射用单克隆抗体，属免疫检查点抑制剂（PD-1抑制剂），通常以针剂形式提供，每瓶常见含量为100mg。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-pill-icon\">💡\u003C/span>\n        白蛋白紫杉醇：注射用，属于紫杉类化疗药，采用蛋白包裹技术，更利于溶解和输注。每瓶常见规格为100mg。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-pill-icon\">💡\u003C/span>\n        铂类药物（如奈达铂、顺铂、卡铂）：多为注射剂型，规格多样，具体选择需根据患者个体情况调整。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"esoph-tip-text\">正确做法：所有药物均在专业医院静脉滴注，不可自行使用。不同剂型不可互换，按说明和医生指导选择适宜品种和规格。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 02 药物作用机制 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.23em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(240, 239, 237) 65%, rgb(234, 246, 251) 100%); padding: 12px 20px 5px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 免疫药物与化疗药的作用机制\u003C/h2>\n  \u003Cdiv class=\"esoph-section\">\n    \u003Cul class=\"esoph-info-list\">\n      \u003Cli>\n        \u003Cspan class=\"esoph-light-icon\">🔬\u003C/span>\n        信迪利单抗：阻断PD-1通路，解除肿瘤对免疫系统的抑制，恢复免疫细胞的杀伤功能。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-light-icon\">🔬\u003C/span>\n        白蛋白紫杉醇：干扰细胞有丝分裂，阻止癌细胞分裂增殖。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-light-icon\">🔬\u003C/span>\n        铂类药物：破坏细胞DNA结构，使异常细胞无法继续生存和繁殖。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"esoph-highlight-box\">\n      \u003Cspan class=\"esoph-flask-icon\">☑️\u003C/span>\n      \u003Cspan style=\"color:#394857;\">\n        这些机制互为补充，联合用药时能从不同层面对抗异常细胞。具体用法需遵从医生建议，切不可擅自更改。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 03 正确用法用量、联合使用原则 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.25em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(248, 245, 252) 70%, rgb(236, 247, 244) 100%); padding: 12px 20px 5px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用药方法与联合用药原则\u003C/h2>\n  \u003Cdiv class=\"esoph-section\">\n    \u003Cul class=\"esoph-info-list\">\n      \u003Cli>\n        \u003Cspan class=\"esoph-clock-icon\">⏰\u003C/span>\n        \u003Cb>信迪利单抗：\u003C/b>通常每2或3周静脉滴注一次，输液过程约30-60分钟；剂量根据体重、疗程进展调整，详见说明书及医生定制方案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-clock-icon\">⏰\u003C/span>\n        \u003Cb>白蛋白紫杉醇、铂类药物：\u003C/b>按化疗周期（如3周为一周期）静脉滴注，配合免疫药物时多在同一天或短时间内顺序输液。每次输液前需评估肝肾功能。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-clock-icon\">⏰\u003C/span>\n        \u003Cb>联合用药的顺序：\u003C/b>部分医院推荐先给免疫药物，再用化疗药，利于药效的协同发挥；但具体顺序视医院方案略有不同。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"esoph-tip-text\">需要注意：严格按照医生排定的时间表和剂量使用，未到下次给药时间不可擅自提前或延迟。\u003C/p>\n    \u003Cdiv class=\"esoph-case-box\">临床上，不少患者因自作主张调整间隔或剂量，导致药效受损或者副作用加重。一定要避免此类行为。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 04 药物不良反应与安全处理 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.25em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(244, 248, 250) 60%, rgb(253, 246, 239) 100%); padding: 12px 20px 5px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 常见不良反应及处理方法\u003C/h2>\n  \u003Cdiv class=\"esoph-section\">\n    \u003Cul class=\"esoph-info-list\">\n      \u003Cli>\n        \u003Cspan class=\"esoph-rx-icon\">⚠️\u003C/span>\n        信迪利单抗可引发免疫相关副作用，常见有皮疹、乏力、轻度发热等。少数人会发生肝炎、肠炎等免疫反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-rx-icon\">⚠️\u003C/span>\n        白蛋白紫杉醇常见骨髓抑制（如白细胞和血小板下降）、脱发、局部静脉刺激反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-rx-icon\">⚠️\u003C/span>\n        铂类药物可见恶心、呕吐、耳鸣、肾功能损害等。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"esoph-highlight-box\">\n      \u003Cspan class=\"esoph-bell-icon\">🔔\u003C/span>\n      \u003Cspan style=\"color:#525252;\">正确做法：出现持续高热、严重乏力、皮肤黄染、明显呕吐或排便异常，需立即联系医务人员，勿等待自行缓解。\u003C/span>\n    \u003C/div>\n    \u003Cdiv style=\"margin-top:13px;color:#728b99;font-size:1.02em;\">数据表明，联合用药相关重度不良反应发生率约10%-25%\u003Cspan style=\"margin-left:5px;\">（参考文献1）\u003C/span>，多为骨髓抑制和免疫相关炎症，绝大多数可通过及早识别和支持治疗缓解。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 特殊人群与用药调整 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.24em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(239, 230, 225) 70%, rgb(231, 252, 250) 100%); padding: 12px 20px 5px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 老年人及特殊体质的用药说明\u003C/h2>\n  \u003Cdiv class=\"esoph-section\">\n    \u003Cul class=\"esoph-info-list\">\n      \u003Cli>\n        \u003Cspan class=\"esoph-user-icon\">👨‍🦳\u003C/span>\n        老年人（65岁及以上）和肾、肝功能减退的患者，推荐起始剂量适度下调，并密切监测用药后肝肾功能、血常规变化。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-user-icon\">👨‍👩‍👦\u003C/span>\n        孕妇、哺乳期妇女：该类药物均不推荐用于孕期和哺乳期，有生育需求者需提前与医生沟通避孕方案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-user-icon\">🧑‍🦲\u003C/span>\n        合并多种基础疾病（如高血压、糖尿病、血管病变）患者，个体化调整剂量，避免与疾病管理药物产生相互作用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"esoph-case-box\">一位70岁患者在肾功能异常后由原方案调整为更温和的铂类药物方案并减少剂量，有效降低了风险，提高了耐受性。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 06 药物相互作用 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.23em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(252, 247, 236) 74%, rgb(230, 251, 250) 100%); padding: 12px 20px 5px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药物相互作用不可忽视\u003C/h2>\n  \u003Cdiv class=\"esoph-section\">\n    \u003Cul class=\"esoph-info-list\">\n      \u003Cli>\n        \u003Cspan class=\"esoph-intract-icon\">⚡\u003C/span>\n        免疫类药物（如信迪利单抗）不建议与糖皮质激素、免疫抑制剂联用，如有不可避免需求，需专业医生评估。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-intract-icon\">⚡\u003C/span>\n        紫杉醇、铂类与部分抗生素、抗癫痫药物及肝酶诱导剂有明显相互作用，可能增加毒性或降低疗效。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-intract-icon\">⚡\u003C/span>\n        与中草药、保健品共同用药存在未知风险。所有额外补充药物请提前报备医生。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"esoph-tip-text\">正确做法：启用新药前主动列出正在服用的全部药物，交由主管医生逐一审核，避免隐患。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 07 储存条件与使用技巧 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.24em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(246, 247, 254) 77%, rgb(234, 251, 239) 100%); padding: 12px 20px 5px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存、运输及漏服处理方法\u003C/h2>\n  \u003Cdiv class=\"esoph-section\">\n    \u003Cul class=\"esoph-info-list\">\n      \u003Cli>\n        \u003Cspan class=\"esoph-storage-icon\">📦\u003C/span>\n        信迪利单抗、白蛋白紫杉醇及铂类均需于2-8°C冷藏，避免阳光直射。严格遵循说明书标注的运输条件。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-storage-icon\">📦\u003C/span>\n        未用完的药物应由医护人员回收，不可自行保存或重复使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-storage-icon\">📦\u003C/span>\n        若漏服、延迟输液，不可自行补用，下周期根据医生建议调整；严禁擅自加量或缩短间隔。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"esoph-tip-text\">过期、变色、沉淀的药品禁止使用。发现异常药品应联系医院药房妥善处理。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 08 真实用药案例参考 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.25em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(246, 250, 248) 78%, rgb(245, 239, 230) 100%); padding: 12px 20px 7px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 典型用药案例带来的启示\u003C/h2>\n  \u003Cdiv class=\"esoph-section\">\n    \u003Cul class=\"esoph-info-list\">\n      \u003Cli>\n        \u003Cspan class=\"esoph-case-icon\">📝\u003C/span>\n        有位老年男性患者在使用信迪利单抗联合白蛋白紫杉醇和铂类方案后，因肾功能异常，铂类药物调整，有效减少了副作用，疗程顺利推进。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-case-icon\">📝\u003C/span>\n        临床发现，部分患者盲目相信中草药、保健品，与免疫药物同用，引发不良反应，一定要警惕药物叠加的隐患。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"esoph-case-icon\">📝\u003C/span>\n        个别患者化疗间隔期未遵医嘱调整时间，导致血象下降严重，提醒严格按时按量用药，按时复查各项指标。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"esoph-highlight-box\" style=\"margin-top:14px;\">\n      \u003Cspan class=\"esoph-star-icon\">🌟\u003C/span>\n      \u003Cspan style=\"color:#39666d;\">每一次用药调整都应在医生指导下进行，绝不可自行尝试。安全和疗效同样重要。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 参考文献部分 -->\n  \u003Ch2 class=\"esoph-drug-subtitle\" style=\"font-size: 1.24em; margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(255, 253, 236) 78%, rgb(215, 247, 235) 100%); padding: 12px 20px 7px 32px; border-radius: 13px; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n  \u003Col class=\"esoph-ref-list\" style=\"\">\n    \u003Cli>\n      \u003Cspan style=\"color:#26344b;\">\u003Cb>[1]\u003C/b> Chen, Y., Wang, W., Li, Y., et al. (2022). Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined with Chemotherapy for Esophageal Cancer: A Systematic Review and Meta-Analysis. \u003Ci>Frontiers in Oncology\u003C/i>, 12, 854433.\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cspan style=\"color:#26344b;\">\u003Cb>[2]\u003C/b> Zhang, X., Zhao, X., Zhang, Y., et al. (2019). A review of immune checkpoint inhibitors in esophageal squamous cell carcinoma. \u003Ci>Journal of Hematology & Oncology\u003C/i>, 12(1), 126.\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cspan style=\"color:#26344b;\">\u003Cb>[3]\u003C/b> Lu, M., Zhang, Y., Ma, D., et al. (2021). Albumin-bound paclitaxel in cancer therapy: A review of current evidence and future perspectives. \u003Ci>OncoTargets and Therapy\u003C/i>, 14, 2281-2293.\u003C/span>\n    \u003C/li>\n  \u003C/ol>\n\n  \u003C!-- 总结 -->\n  \u003Cdiv class=\"esoph-summary-box\" style=\"border-radius:12px;background:linear-gradient(96deg,#f7fafd 70%,#f7f9ea 100%);padding:18px 18px 14px 32px;margin-top:28px;color:#425462;font-size:1.12em;\">\n    \u003Cb>小结：\u003C/b>免疫药物联合化疗已成为食管癌药物治疗的新选择。关注剂型、按时用药、合理调整方案、密切监测不良反应，是保证用药安全和疗效的关键。遇到不适及时报告医护，不盲目自调方案。安全第一，疗效为本，让专业团队护航每一程。\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.esoph-drug-guide-container {font-family:\"PingFang SC\",\"Segoe UI\",Arial,sans-serif;}\n.esoph-drug-title {text-align:center;font-size:2.1em;color:#24527f;letter-spacing:1.5px;font-weight:bold;line-height:1.12;margin-bottom:24px;}\n.esoph-bg-title {background:linear-gradient(120deg,#f2f5f8 60%,#e9f7f4);}\n.esoph-drug-subtitle {border-left:6px solid #64afa9;color:#005260;margin-bottom:5px;margin-left:-5px;font-weight:bold;line-height:1.7;}\n.esoph-section {padding:18px 14px 8px 10px;margin-top:-7px;margin-bottom:18px;}\n.esoph-info-list {list-style:none;padding:0;margin:0;}\n.esoph-info-list li {margin-bottom:13px;margin-left:0px;font-size:1.08em;color:#314856;display:flex;align-items:flex-start;}\n.esoph-pill-icon, .esoph-light-icon, .esoph-clock-icon, .esoph-user-icon, .esoph-intract-icon, .esoph-storage-icon, .esoph-case-icon, .esoph-rx-icon {font-size:1.17em;margin-left:1px;margin-right:8px;}\n.esoph-tip-text {background:rgba(215,238,232,0.23);padding:8px 16px;border-radius:8px;font-size:1.02em;margin-top:6px;margin-bottom:6px;color:#1d654b;}\n.esoph-highlight-box {background:linear-gradient(96deg,#f3f8fa 66%,#fafae8 100%);border-radius:8px;padding:10px 18px 10px 34px;margin-top:8px;margin-bottom:6px;line-height:1.7;}\n.esoph-flask-icon, .esoph-bell-icon, .esoph-star-icon {margin-right:8px;font-size:1.13em;}\n.esoph-case-box {background:linear-gradient(101deg,#fdf6e9 84%,#e6f6fa 100%);border-radius:7px;padding:8px 18px 8px 34px;line-height:1.66;color:#876133;margin-top:15px;margin-bottom:13px;font-size:1.07em;}\n.esoph-ref-list {padding-left:24px;line-height:1.9;}\n.esoph-summary-box {font-size:1.10em;margin-bottom:0;}\n@media (max-width:550px) {\n  .esoph-drug-title {font-size:1.32em;padding:8px 0;}\n  .esoph-section {padding-left:0;padding-right:0;}\n  .esoph-drug-subtitle {font-size:1.03em;padding-left:12px;padding-right:8px;}\n  .esoph-ref-list {padding-left:8px;}\n  .esoph-highlight-box, .esoph-case-box, .esoph-summary-box {padding-left:16px;padding-right:7px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"esoph-drug-guide-container\" style=\"max-width:780px;margin:0 auto;padding:32px 20px 32px ",352,"2025-08-06 14:45:43","食管癌, 免疫治疗, 化疗, 信迪利单抗, 白蛋白紫杉醇, 药物不良反应, 联合用药, 老年人用药","探索免疫药物信迪利单抗与化疗药物联合应用在食管癌治疗中的新进展，解析用药方法、不良反应及特殊人群用药，助力患者安全有效治疗。","2025-08-19 14:26:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]